Wiley Matthew T.
SEC-identified person · CIK 1759703 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Mind Medicine (Mindmed) Inc. MNMD | Chief Commercial Officer | filed 2025 - 2026 |
| Bioxcel Therapeutics, Inc. BTAI ] | Chief Commercial Officer | filed 2022 - 2025 |
| Vyne Therapeutics Inc. VYNE | Chief Commercial Officer | filed 2020 - 2021 |
| Foamix Pharmaceuticals Ltd. FOMX | Chief Commercial Officer | filed 2018 - 2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.